Misleading clinical evidence and systematic reviews on ivermectin for COVID-19

BMJ Evid Based Med. 2022 Jun;27(3):156-158. doi: 10.1136/bmjebm-2021-111678. Epub 2021 Apr 22.

Authors

Luis Ignacio Garegnani¹, Eva Madrid², Nicolás Meza³

Affiliations

¹ Research Department. Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
² Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile.
³ Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile nicolas.meza@uv.cl.

PMID: 33888547
DOI: 10.1136/bmjebm-2021-111678

No abstract available

Keywords: COVID-19; infectious disease medicine; prescription drugs; quality of health care.

MeSH terms

COVID-19*
Humans
Ivermectin / therapeutic use
SARS-CoV-2

Substances

Ivermectin